Physician profile
George C Scott
NPI 1942288873
$2,983.25
in general payments reported to CMS, 2019-2025
21 companies · $479 in 2025
The $479 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $295 · 2020: $610 · 2021: $887 · 2022: $307 · 2023: $258 · 2024: $147 · 2025: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $885.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $884.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $911.52 | 2019-2023 | Orilissa, Lo Loestrin Fe, Liletta |
| Mayne Pharma Commercial LLC | $555.67 | 2021-2025 | |
| Therapeuticsmd, INC. | $291.32 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $229.22 | 2023-2025 | Myfembree, Gemtesa |
| Pfizer INC. | $198.66 | 2020-2023 | |
| Exeltis, USA INC. | $127.97 | 2023-2025 | Slynd |
| Evofem Biosciences, INC. | $125.34 | 2021-2025 | Solosec, Phexx, Phexxi |
| Mylan Pharmaceuticals INC. | $89.23 | 2020-2021 | |
| Myovant Sciences INC. | $77.34 | 2021 | |
| Lupin INC. | $72.35 | 2020 | |
| Hologic Sales and Service, LLC | $61.69 | 2019-2020 | |
| Roche Diagnostics Corporation | $46.18 | 2019-2021 | |
| Ascend Therapeutics US, LLC | $45.38 | 2021 | |
| Amag Pharmaceuticals, INC. | $34.00 | 2019 | |
| Avion Pharmaceuticals | $24.64 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mycovia Pharmaceuticals, INC. | $19.82 | 2023 | Vivjoa |
| Zyla Life Sciences, INC. | $17.48 | 2020 | |
| Agile Therapeutics, INC. | $16.79 | 2021 | |
| Allergan, INC. | $13.05 | 2020 | |
| Bard Access Systems, INC. | $13.00 | 2019 | |
| Vertical Pharmaceuticals, LLC | $12.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.